Reprint

10th Anniversary of JCM

Recent Diagnostic and Therapeutic Advance in Gastroenterology and Hepatopancreatobiliary Medicine

Edited by
August 2023
164 pages
  • ISBN978-3-0365-8392-1 (Hardback)
  • ISBN978-3-0365-8393-8 (PDF)

This book is a reprint of the Special Issue 10th Anniversary of JCM—Recent Diagnostic and Therapeutic Advance in Gastroenterology and Hepatopancreatobiliary Medicine that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

The year 2021 marks the 10th anniversary of Journal of Clinical Medicine, and as one of the major sections of JCM, we are launching a 10th anniversary Special Issue in the section “Gastroenterology & Hepatopancreatobiliary Medicine”.

We accepted papers for the Special Issue, titled "Recent diagnostic and therapeutic advance in Gastroenterology & Hepatopancreatobiliary Medicine". This medical field is a complex and wide-ranging field that deals with diseases in multiple organs such as the gastrointestinal tract and hepatobiliary pancreas. With recent advances in diagnostic imaging and interventional treatment, those in endoscopic diagnosis and treatment, those in functional test and those in genetic diagnosis and drug therapy, including the molecular-targeted therapy, many new medical findings have been accumulated.

In this Special Issue, we looked for reports that make full use of advances in diagnostics and therapeutics in the field of Gastroenterology and Hepatopancreatobiliary Medicine.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
TXI; sessile serrated lesion; hyperplastic polyp; colonoscopy; endoscopic submucosal dissection; colorectal tumor; traction method; carbon dioxide; CO2 insufflation; abdominal pain; abdominal distention; transnasal endoscopy; health check; tranexamic acid; gastrointestinal bleeding; mortality; thromboembolic events; liver metastases; colorectal liver metastases; non-colorectal and non-neuroendocrine liver metastases; liver resection; Crohn’s disease; biologics; small-molecule drugs; health-related quality of life (HRQoL); gastric cancer; gastric cancer screening; endoscopy; H. pylori; eradication therapy; n/a; functional bowel disorders; gut microbiota; personalized diet; machine learning; personalized medicine; Turkey; machine perfusion; normothermic; hypothermic; liver transplant; survival; Crohn’s disease; ustekinumab; perianal fistula; radiological fistula remission; metastatic pancreatic carcinoma; FOLFIRINOX; sarcopenia; oxaliplatin; sarcopenia; L3 skeletal muscle index; percutaneous endoscopic gastrostomy; prognostic factor